News

Veru Inc.: Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...
Veru Participates in a Virtual Investor KOL Connect Segment
Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President ...